These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 32496438)

  • 1. Corticosteroid-Flared Hepatotoxicity Reversed With l -Carnitine Therapy in a Patient Treated With Long-Term Valproic Acid.
    Goren BI; Selvi E; Bektas B; Arslan F
    Am J Ther; 2022 Nov-Dec 01; 29(6):e774-e776. PubMed ID: 32496438
    [No Abstract]   [Full Text] [Related]  

  • 2. Evidence for a potential protective effect of carnitine-pantothenic acid co-treatment on valproic acid-induced hepatotoxicity.
    Felker D; Lynn A; Wang S; Johnson DE
    Expert Rev Clin Pharmacol; 2014 Mar; 7(2):211-8. PubMed ID: 24450420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatotoxic effects in a child receiving valproate and carnitine.
    Murphy JV; Groover RV; Hodge C
    J Pediatr; 1993 Aug; 123(2):318-20. PubMed ID: 8345435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Valproic acid-induced idiosyncratic liver injury in 4 cases].
    Xiong H; Liu CT; Zhang YH; Bao XH; Jiang YW; Zhao H; Wu XP; Qin J
    Zhonghua Er Ke Za Zhi; 2012 Dec; 50(12):890-4. PubMed ID: 23324142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of L-carnitine treatment for valproate-induced hepatotoxicity.
    DeVivo DC
    Neurology; 2002 Feb; 58(3):507-8. PubMed ID: 11839873
    [No Abstract]   [Full Text] [Related]  

  • 6. Valproic Acid and the Liver Injury in Patients with Epilepsy: An Update.
    Guo HL; Jing X; Sun JY; Hu YH; Xu ZJ; Ni MM; Chen F; Lu XP; Qiu JC; Wang T
    Curr Pharm Des; 2019; 25(3):343-351. PubMed ID: 30931853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of carnitine supplementation during valproic acid therapy.
    Raskind JY; El-Chaar GM
    Ann Pharmacother; 2000 May; 34(5):630-8. PubMed ID: 10852092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Valproic acid induced-idiosyncratic hepatotoxicity].
    Mata Zubillaga D; Prieto Espuñes S; Ferrero de la Mano L; Herrero Mendoza B
    An Pediatr (Barc); 2008 Nov; 69(5):492-3. PubMed ID: 19128756
    [No Abstract]   [Full Text] [Related]  

  • 9. Valproic-acid-induced thrombocytopenia and hepatotoxicity: discontinuation of treatment?
    Lackmann GM
    Pharmacology; 2004 Feb; 70(2):57-8. PubMed ID: 14685007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of L-carnitine treatment for valproate-induced hepatotoxicity.
    Bohan TP; Helton E; McDonald I; König S; Gazitt S; Sugimoto T; Scheffner D; Cusmano L; Li S; Koch G
    Neurology; 2001 May; 56(10):1405-9. PubMed ID: 11376200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Science review: carnitine in the treatment of valproic acid-induced toxicity - what is the evidence?
    Lheureux PE; Penaloza A; Zahir S; Gris M
    Crit Care; 2005 Oct; 9(5):431-40. PubMed ID: 16277730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valproic acid administration for hepatic fibrosis: a balance between antifibrotic efficacy and hepatotoxicity.
    Ikura Y; Iwasa Y; Ueda M
    Hepatology; 2010 Jun; 51(6):2227-8; author reply 2228. PubMed ID: 20513011
    [No Abstract]   [Full Text] [Related]  

  • 13. Valproic acid and fatalities in children: a review of individual case safety reports in VigiBase.
    Star K; Edwards IR; Choonara I
    PLoS One; 2014; 9(10):e108970. PubMed ID: 25302991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatotoxicity and valproate therapy.
    Betrosian A; Frantzeskaki F
    Intern Med J; 2006 Nov; 36(11):752-4. PubMed ID: 17040368
    [No Abstract]   [Full Text] [Related]  

  • 15. [L-carnitine in valproic acid-induced hyperammonemia].
    Martín-del Rincón JP; Llompart-Pou JA; Ferreruela M; Velasco J
    Med Intensiva; 2014 Mar; 38(2):124-5. PubMed ID: 23017629
    [No Abstract]   [Full Text] [Related]  

  • 16. A case of acute valproic acid poisoning treated successfully with L-carnitine.
    Papaseit E; Farré M; López MJ; Clemente C; Campodarve I
    Eur J Emerg Med; 2012 Feb; 19(1):57-8. PubMed ID: 22223129
    [No Abstract]   [Full Text] [Related]  

  • 17. Potential relationships between transaminase abnormality and valproic acid clearance or serum carnitine concentrations in Japanese epileptic patients.
    Goto S; Seo T; Hagiwara T; Ueda K; Yamauchi T; Nagata S; Ando Y; Ishitsu T; Nakagawa K
    J Pharm Pharmacol; 2008 Feb; 60(2):267-72. PubMed ID: 18237476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valproate induced encephalopathy treated with carnitine in an adult.
    Beversdorf D; Allen C; Nordgren R
    J Neurol Neurosurg Psychiatry; 1996 Aug; 61(2):211. PubMed ID: 8708702
    [No Abstract]   [Full Text] [Related]  

  • 19. [Severe liver damage following administration of valproic acid (Depakine)].
    Coeckelberghs M; van Caillie-Bertrand M; Bultinck J; Clara R
    Ned Tijdschr Geneeskd; 1980 Aug; 124(34):1428-31. PubMed ID: 6774268
    [No Abstract]   [Full Text] [Related]  

  • 20. Carnitine in the treatment of valproic acid-induced toxicity.
    Lheureux PE; Hantson P
    Clin Toxicol (Phila); 2009 Feb; 47(2):101-11. PubMed ID: 19280426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.